Gemcitabine Plus Vinorelbine in Elderly or Unfit Patients With Non-Small Cell Lung Cancer

British Journal of Cancer - United Kingdom
doi 10.1054/bjoc.2000.1304
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Gemcitabine Plus Vinorelbine in Advanced Non-Small Cell Lung Cancer: A Phase II Study of Three Different Doses

British Journal of Cancer
Cancer ResearchOncology
2000English

Pemetrexed Versus Vinorelbine Treatment of Advanced Non-Squamous Non-Small Cell Lung Cancer in Elderly Patients

Molecular and Clinical Oncology
Cancer ResearchOncology
2013English

Advanced Non-Small Cell Lung Cancer in Elderly Patients

Breathe
PulmonaryRespiratory Medicine
2012English

Chemotherapy for Non-Small Cell Lung Cancer in Elderly Patients

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
2005English

Phase III Study of Cisplatin With Pemtrexed or Vinorelbine Plus Concurrent Late Course Accelerated Hyperfractionated Radiotherapy in Patients With Unresectable Stage III Non-Small Cell Lung Cancer

Oncotarget
Oncology
2016English

Efficacy and Safety of Apatinib Plus Vinorelbine in Patients With Wild-Type Advanced Non–Small Cell Lung Cancer After Second-Line Treatment Failure

JAMA network open
Medicine
2020English

162P: Molecular Markers in Advanced Non Small Cell Lung Cancer Patients Receiving Gemcitabine & Cisplatin

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2016English

P3.01-36 Prognostic Factors in Elderly Patients With Advanced Non-Small Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Combination Studies With Gemcitabine in the Treatment of Non-Small-Cell Lung Cancer

British Journal of Cancer
Cancer ResearchOncology
1998English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy